Want to see IN:ACUTAAS full AI Analyst Report?
Acutaas Chemicals (ACUTAAS) Financial Statements
Acutaas Chemicals Financial Overview
Acutaas Chemicals's market cap is currently $327.70B. The company's EPS TTM is $33.38; its P/E ratio is 74.64; and it has a dividend yield of 0.06%. Acutaas Chemicals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 25 | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.07B | $ 6.17B | $ 5.18B | $ 3.41B | $ 2.40B |
| Gross Profit | $ 4.55B | $ 2.86B | $ 1.94B | $ 1.22B | $ 776.58M |
| Operating Income | $ 3.71B | $ 1.11B | $ 950.95M | $ 764.26M | $ 382.67M |
| EBITDA | $ 2.32B | $ 1.27B | $ 1.08B | $ 811.14M | $ 438.14M |
| Net Income | $ 1.59B | $ 832.90M | $ 719.46M | $ 539.99M | $ 274.70M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.49B | $ 586.70M | $ 615.46M | $ 26.85M | $ 38.22M |
| Total Assets | $ 15.49B | $ 7.67B | $ 6.59B | $ 4.13B | $ 2.32B |
| Total Debt | $ 129.39M | $ 36.00M | $ 8.44M | $ 1.37B | $ 594.20M |
| Net Debt | $ -2.36B | $ -269.32M | $ -94.53M | $ 1.34B | $ 555.98M |
| Total Liabilities | $ 2.29B | $ 1.73B | $ 1.37B | $ 2.46B | $ 1.20B |
| Stockholders' Equity | $ 13.10B | $ 5.94B | $ 5.22B | $ 1.67B | $ 1.12B |
| Cash Flow | |||||
| Free Cash Flow | $ -763.00M | $ -308.73M | $ -424.18M | $ -794.33M | $ 54.71M |
| Operating Cash Flow | $ 1.18B | $ 655.30M | $ -86.60M | $ 271.45M | $ 270.77M |
| Investing Cash Flow | $ -2.24B | $ -330.44M | $ -1.24B | $ -1.00B | $ -239.44M |
| Financing Cash Flow | $ 2.61B | $ -122.50M | $ 1.40B | $ 721.08M | $ 1.94M |
Currency in INR
